Your browser doesn't support javascript.
loading
The ß-Secretase BACE1 in Alzheimer's Disease.
Hampel, Harald; Vassar, Robert; De Strooper, Bart; Hardy, John; Willem, Michael; Singh, Neeraj; Zhou, John; Yan, Riqiang; Vanmechelen, Eugeen; De Vos, Ann; Nisticò, Robert; Corbo, Massimo; Imbimbo, Bruno Pietro; Streffer, Johannes; Voytyuk, Iryna; Timmers, Maarten; Tahami Monfared, Amir Abbas; Irizarry, Michael; Albala, Bruce; Koyama, Akihiko; Watanabe, Naoto; Kimura, Teiji; Yarenis, Lisa; Lista, Simone; Kramer, Lynn; Vergallo, Andrea.
Afiliación
  • Hampel H; Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine, Pitié-Salpêtrière Hospital, Paris, France. Electronic address: harald_hampel@eisai.com.
  • Vassar R; Department of Neurology, Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • De Strooper B; Department of Neurosciences, KU Leuven, Leuven, Belgium; Centre for Brain and Disease Research, VIB (Flanders Institute for Biotechnology), Leuven, Belgium; Dementia Research Institute, University College London, London, United Kingdom.
  • Hardy J; Department of Molecular Neuroscience and Reta Lilla Weston Laboratories, Queen Square Institute of Neurology, University College London, London, United Kingdom.
  • Willem M; Chair of Metabolic Biochemistry, Biomedical Center, Faculty of Medicine, Ludwig Maximilians University Munich, Munich, Germany.
  • Singh N; Department of Neuroscience, University of Connecticut Health, Farmington, Connecticut.
  • Zhou J; Department of Neuroscience, University of Connecticut Health, Farmington, Connecticut.
  • Yan R; Department of Neuroscience, University of Connecticut Health, Farmington, Connecticut.
  • Vanmechelen E; ADx NeuroSciences NV, Ghent, Belgium.
  • De Vos A; ADx NeuroSciences NV, Ghent, Belgium.
  • Nisticò R; Laboratory of Neuropharmacology, EBRI Rita Levi-Montalcini Foundation, Rome, Italy; School of Pharmacy, Department of Biology, University of Rome "Tor Vergata," Rome, Italy.
  • Corbo M; Department of Neurorehabilitation Sciences, Casa Cura Policlinico, Milan, Italy.
  • Imbimbo BP; Department of Research and Development, Chiesi Farmaceutici, Parma, Italy.
  • Streffer J; Reference Center for Biological Markers of Dementia, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium; UCB Biopharma SPRL, Braine-l'Alleud, Belgium.
  • Voytyuk I; Department of Neurosciences, KU Leuven, Leuven, Belgium; Centre for Brain and Disease Research, VIB (Flanders Institute for Biotechnology), Leuven, Belgium; ALBORADA Drug Discovery Institute, University of Cambridge, Cambridge, United Kingdom.
  • Timmers M; Reference Center for Biological Markers of Dementia, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium; Janssen Research and Development, a division of Janssen Pharmaceutica, Beerse, Belgium.
  • Tahami Monfared AA; Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
  • Irizarry M; Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey.
  • Albala B; Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey.
  • Koyama A; Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey.
  • Watanabe N; Eisai Company Ltd., Tokyo, Japan.
  • Kimura T; Eisai Company Ltd., Tokyo, Japan.
  • Yarenis L; Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey.
  • Lista S; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine, Pitié-Salpêtrière Hospital, Paris, France; Institute of Memory and Alzheimer's Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France; Brain & Spine Institute, INSERM U 1127, CNRS UMR 7225, Paris, France.
  • Kramer L; Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey.
  • Vergallo A; Neurology Business Group, Eisai Inc., Woodcliff Lake, New Jersey; Sorbonne University, GRC No. 21, Alzheimer Precision Medicine, Pitié-Salpêtrière Hospital, Paris, France; Institute of Memory and Alzheimer's Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris, France; Brain & Spi
Biol Psychiatry ; 89(8): 745-756, 2021 04 15.
Article en En | MEDLINE | ID: mdl-32223911
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Secretasas de la Proteína Precursora del Amiloide / Enfermedad de Alzheimer Límite: Animals / Humans Idioma: En Revista: Biol Psychiatry Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Secretasas de la Proteína Precursora del Amiloide / Enfermedad de Alzheimer Límite: Animals / Humans Idioma: En Revista: Biol Psychiatry Año: 2021 Tipo del documento: Article